Measurement of des-γ-carboxy prothrombin levels in hemodialysis patients positive for anti-hepatitis virus C antibody

Clinical Nephrology

Volumn 58, Issue 4, 2002, Pages 296-300

  Kato, A ^a   Yasuda, H ^a   Togawa, A ^a   Yamamoto, T ^a   Yonemura, K ^a   Maruyama, T ^a   Maruyama, Y ^a   Hishida, A ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AFP; False positive; Hemodialysis; PIVKA II; Warfarin

Indexed keywords

ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BIOLOGICAL MARKER; DECARBOXYPROTHROMBIN; DIALYSIS FLUID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE COUNT; THROMBOSIS; THROMBOTEST; VITAMIN K DEFICIENCY;

EID: 0036790610     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58296     Document Type: Article

References (25)

1. Bach AU, Anderson SA, Foley AL, Williams EC, Suttie JW 1996 Assessment of vitamin K status in human subjects administered "minidose" warfarin. Am J Clin Nutr 64: 894-902
2. Bellizzi V, De Nicola L, Ames P, Libertino R, Terracciano V, Cianciaruso B 1997 Fetal proteins and chronic treatment with low-dose erythropoietin. J Lab Clin Med 129: 193-199
3. Cases A, Filella X, Molina R, Ballesta AM, Lopez-Pedret J, Revert L 1991 Tumor markers in chronic renal failure and hemodialysis patients. Nephron 57: 183-186
4. Cushman M, Booth SL, Possidents CJ, Davidson KW, Sadowaki JA, Bovill EG 2001 The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 112: 572-577
5. De Montalemhert M, Lenoir G, Saint-Raymond A, Rey J, Lefrère JJ 1992 Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol 45: 180-181
6. Deyashiki Y, Nishioka Y, Takahashi K, Kosaka Y, Suzuki K 1989 Evaluation of des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma. Cancer 64: 2546-2551
7. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F 2001 Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 38: 1009-1015
8. Filella X, Cases A, Molina R, Jo J, Bedini JL, Revert L, Ballesta AM 1990 Tumor markers in patients with chronic renal failure. Int J Biol Markers 5: 85-88
9. Hamamura K, Shiratori Y, Shiina S, Imamura M, Obi S, Sato S, Yoshida H, Omata S 2000 Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-γ-carboxy prothrombin and low serum α-fetoprotein. Cancer 88: 1557-1564
10. Harauchi T, Takano K, Matsuura M, Yoshizaki T 1986 Liver and plasma levels of descarboxyprothrombin (PIVKA II) in vitamin K deficiency in rats. Jpn J Pharmacol 40: 491-499
11. Ishida H, Agishi T, Koyama I, Sawada T, Murakami T, Utsumi K, Tsuji K, Kawase T, Ishii Y, Ishimori I, Kaneko I, Tojimbara T, Nakajima I, Mineshima M, Fuchinoue S, Yoshioka T 2001 Hemodialysis paradox: survey on the incidence rate of hepatocellular carcinoma in antihepatic virus C-antibody-positive chronic hemodialysis patients. Artif Organs 25: 58-60
12. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takahgi T, Toyota T, Takahashi T, Kasukawa R and the South Tohoku District Study Group 2000 Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. Am J Gastroenterol 95: 1036-1040
13. Kanazumi N, Takeda S, Inoue S, Ohshima K, Sugimoto H, Kaneko T, Watanabe K, Nakao A 2000 PIVKA-II during perioperative period in patients with hepatobiliary-pancreatic diseases. Hepatogastroenterology 47: 1695-1699
14. Koike Y, Shiratori Y, Sato S, Obi S, Teratani I, Imamura M, Yoshida H, Shiina S, Omata M 2001 Des-γ-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma. A prospective analysis of 227 patients. Cancer 91: 561-569
15. Lamerz R, Runge M, Stieber P, Meissner E 1999 Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases. Anticancer Res 19: 2489-2493
16. Lefrère JJ, Girot R, Lerable J, Gozin D, Ducreux M, Chekara K, Soulier JP 1989 Study of the disappearance time of des-gamma-carboxyprothrombin under different conditions. Thromb Res 55: 645-649
17. Liebman HA 1989 Isolation and characterization of a hepatoma-associated abnormal (des-α-carboxy) prothrombin. Cancer Res 49: 6493-6497
18. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B 1984 Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427-1431
19. Mackie IJ, Walshe K, Cohen H, McCarthy P Shearer M, Scott SD, Karran SJ, Machin SJ 1986 Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced vitamin K1 concentrations. J Clin Pathol 39: 1245-1249
20. Mita Y, Aoyagi Y, Yanagi M, Suda T, Suzuki Y, Asakura H 1998 The usefulness of detecting des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma. Cancer 82: 1643-1648
21. Nakamura K, Toyohira H, Kariyazono H, Ishibashi M, Saigenji H, Shimokawa S, Taira A 1994 Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces. Artery 21: 148-160
22. Nakayama E, Akiba T, Marumo F, Sato C 2000 Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11: 1896-1902
23. Paiva SAR, Sepe TE, Booth SL, Camilo ME, O'Brien ME, Davidson KW, Sadowski JA, Russel RM 1998 Interaction between vitamin K nutriture and bacterial overgrowth in hypochlorhydria induced by omeprazole. Am J Clin Nutr 68: 699-704
24. Umeki S, Umeli Y 1990 Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients. Med Lab Sci 47: 103-107
25. Yasuda K, Okuda K, Endo N, Ishiwatari K, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y 1995 Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109: 1295-1300